COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,594 Articles (22,415 medRxiv, 8,179 bioRxiv)

Most recent first Previous |  Page 89: Articles 881-890  | Next

Mental health patterns and associated social determinants among university and college students in Sub-Saharan Africa during the COVID-19 pandemic era : A Scoping Review Protocol
MUTURIKI, M., Mapukata, N., Chauke, L., Jewett, S.
10.1101/2024.10.08.24315086 — Posted: 2024-10-08
Post-COVID-Syndrome patients might overestimate own cognitive impairment
Woehrstein, S., Matuz, T., Roetzer, L., Karnath, H.-O.
10.1101/2024.10.07.24314894 — Posted: 2024-10-07
Cell-based high-content approach for SARS-CoV-2 neutralization identifies unique monoclonal antibodies and PI3K pathway inhibitors.
Cabel, C. R., Guzman, B. A., Alizadeh, E., Li, S., Holberg, C., Wichaidit, C., Cusanovich, D. A., Paek, A. L., Thatcher, G. R. J., Van Doorslaer, K., Nargi, R. S., Sutton, R. E., Suryadevara, N., Crowe, J. E., Carnahan, R. H., Thorne, C. A., Campos, S. K.
10.1101/2024.10.04.616743 — Posted: 2024-10-07
Chronic infections can generate SARS-CoV-2-like bursts of viral evolution without epistasis
Rodriguez-Horta, E., Strahan, J., Dinner, A., Barton, J. P.
10.1101/2024.10.06.616878 — Posted: 2024-10-07
Spike mRNA Vaccine Encapsulated in a Lipid Nanoparticle Composed of Phospholipid 1,2-Dioleoyl-sn-Glycero-3-Phosphoethanolamine Induced Potent B- and T-cell Responses Associated with Protection against COVID-19 in Hamsters
Quadiri, A., Prakash, S., Zayou, L., Dhanushkodi, N., Chilukuri, A., Ryan, G., Wang, K., Vahed, H., BenMohamed, L.
10.1101/2024.10.05.616797 — Posted: 2024-10-07
Mortality and associated factors among hospitalized COVID 19 patients in Lira regional referral hospital, a cross sectional study.
Ongoli, A., Opio, B., Opollo, M. S., Akello, R. A., Kiweewa, F., Omech, B.
10.1101/2024.10.05.24314935 — Posted: 2024-10-06
Impacts of vaccination on the variant selection of SARS-CoV-2 and the subsequent case hospitalization rate: insights from the first U.S. Omicron wave
LIANG, J., Ding, Z., Zhang, Q., Yuan, H.-Y.
10.1101/2024.10.03.24314829 — Posted: 2024-10-04
Reimagining COVID Vaccine Distribution: Reflecting on Waste and Equity
Greenhalgh, S., Alva, M.
10.1101/2024.10.04.24314854 — Posted: 2024-10-04
Changes in population immunity to omicron SARS-CoV-2 variants and selected Sarbecoviruses from 2020 to 2023 in urban Colombo, Sri Lanka
Bary, F., Karunananda, M. V., Jeewandara, C., Danasekara, S., Guruge, D., Rizan, R., Aberathna, I. S., Ranasinghe, T., Kuruppu, H., Jayamali, J., Perera, L., Chathurangika, H., Gunaratne, A., Dasanthi, N., Ranatunga, C., Ishara, A. W. S., Yatiwelle, S., Wijayamuni, R., Tang, T. K., Townsend, A., Ogg, G. S., Malavige, G. N.
10.1101/2024.10.03.24314822 — Posted: 2024-10-04
Measurement of doctor wellbeing prior to the Covid pandemic: a methodological systematic review
Simons, G., Opalinski, D., Jenkins, J., Boxley, E., Baldwin, D.
10.1101/2024.10.03.24314759 — Posted: 2024-10-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).